Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Equity Average (2020)

Historic Equity Average for Burning Rock Biotech (BNR) over the last 1 years, with Q4 2020 value amounting to $372.0 million.

  • Burning Rock Biotech's Equity Average changed N/A to $372.0 million in Q4 2020 from the same period last year, while for Dec 2020 it was $372.0 million, marking a year-over-year change of. This contributed to the annual value of $93.9 million for FY2024, which is 3199.81% down from last year.
  • As of Q4 2020, Burning Rock Biotech's Equity Average stood at $372.0 million.
  • Over the past 5 years, Burning Rock Biotech's Equity Average peaked at $376.4 million during Q3 2020, and registered a low of $372.0 million during Q4 2020.